10 ng/mL.">
首站-论文投稿智能助手
典型文献
CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
文献摘要:
Objective The aim of this study was to evaluate the impact of serum carcinoembryonic antigen (CEA) in the prediction of pathological complete response (pCR) in locally advanced rectal cancer (LARC) patients treated with neoadjuvant chemoradiotherapy (nCRT). Methods A total of 925 LARC patients who underwent nCRT followed by TME between March 2006 and February 2018 were enrolled at Fudan University Shanghai Cancer Center. Using logistic regression models, we investigated the associations between serum CEA levels and pathological complete remission (pCR). Further stratified analyses were performed according to different CEA thresholds. Results We found that pre-nCRT CEA and post-nCRT CEA were negatively correlated with pCR (P < 0.001). Stratified analyses revealed that when the CEA cutoff value was set to 5 ng/mL, 10.6% of patients with post-nCRT CEA levels > 5 ng/mL achieved pCR. Meanwhile, when the CEA cutoff value was set to 10 ng/mL, only 6.8% of the patients with post-nCRT CEA levels > 10 ng/mL achieved pCR. Conclusion In summary, pre- and post-nCRT CEA levels ≤ 5 ng/mL were favorable predictors of pCR in LACR patients, and the "watch and wait" strategy is not recommended for patients with post-nCRT CEA levels > 10 ng/mL.
文献关键词:
作者姓名:
Lili Shen;Chao Li;Jingwen Wang;Jin Fan;Ji Zhu
作者机构:
Department of Oncology,Nantong Haimen People's Hospital,Haimen Hospital of Nantong University,Nantong 226100,China;Department of Radiotherapy,Huashan Hospital,Fudan University,Shanghai 200032,China;Department of Radiation Oncology,Fudan University Shanghai Cancer Center,Shanghai 200032,China
引用格式:
[1]Lili Shen;Chao Li;Jingwen Wang;Jin Fan;Ji Zhu-.CEA levels predict tumor response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer)[J].肿瘤学与转化医学(英文),2022(04):180-185
A类:
LACR
B类:
CEA,levels,tumor,response,neoadjuvant,chemoradiotherapy,locally,advanced,rectal,cancer,Objective,aim,this,study,was,evaluate,impact,serum,carcinoembryonic,antigen,prediction,pathological,complete,pCR,LARC,patients,treated,nCRT,Methods,total,who,underwent,followed,by,TME,between,March,February,were,enrolled,Fudan,University,Shanghai,Cancer,Center,Using,logistic,regression,models,investigated,associations,remission,Further,stratified,analyses,performed,according,different,thresholds,Results,We,found,that,post,negatively,correlated,Stratified,revealed,when,cutoff,value,set,achieved,Meanwhile,only,Conclusion,In,summary,favorable,predictors,watch,wait,strategy,not,recommended
AB值:
0.492039
相似文献
Is oxygen therapy beneficial for normoxemic patients with acute heart failure? A propensity score matched study
Yue Yu;Ren-Qi Yao;Yu-Feng Zhang;Su-Yu Wang;Wang Xi;Jun-Nan Wang;Xiao-Yi Huang;Yong-Ming Yao;Zhi-Nong Wang-Department of Cardiothoracic Surgery,Changzheng Hospital,Naval Medical University,415 Fengyang Road,Huangpu District,Shanghai 200003,China;Trauma Research Center,Fourth Medical Center and Medical Innovation Research Department of the Chinese PLA General Hospital,51 Fucheng Road,Haidian District,Beijing 100048,China;Department of Burn Surgery,Changhai Hospital,Naval Medical University,Shanghai 200433,China;Medical Research Center of War Injuries and Trauma,Changzheng Hospital,Naval Medical University,Shanghai 200003,China;Department of Pathology,Changhai Hospital,Naval Medical University,Shanghai 200433,China
Identification of hub genes and their novel diagnostic and prognostic significance in pancreatic adenocarcinoma
Duo Zuo;Yongzi Chen;Xinwei Zhang;Zhuozhi Wang;Wenna Jiang;Fan Tang;Runfen Cheng;Yi Sun;Lu Sun;Li Ren;Rui Liu-Department of Clinical Laboratory;Department of Tumor Cell Biology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Biomedical Engineering,Tianjin Medical University,Tianjin 300070,China;Department of Pathology,Tianjin Huanhu Hospital,Tianjin 300350,China;Department of Pathology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,Tianjin Medical University,Tianjin 300070,China;Department of Gastrointestinal Medical Oncology,Tianjin Medical University Cancer Institute and Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer
Yujiao Wang;Xi Jiao;Shuang Li;Huan Chen;Xin Wei;Chang Liu;Jifang Gong;Xiaotian Zhang;Xicheng Wang;Zhi Peng;Changsong Qi;Zhenghang Wang;Yanni Wang;Na Zhuo;Jianling Zou;Henghui Zhang;Jian Li;Lin Shen;Zhihao Lu-Department of Gastrointestinal Oncology,Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Gastric&Colorectal Surgery,The First Hospital of Jilin University,Changchun 130021,China;Genecast Precision Medicine Technology Institute,Beijing 100192,China;Life Sciences Institute,Zhejiang University,Hangzhou 310058,China;Institute of Infectious Diseases,Beijing Ditan Hospital,Capital Medical University,Beijing 100015,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。